Clinical Trials Logo

Filter by:
NCT ID: NCT06070792 Recruiting - CAESAREAN SECTION Clinical Trials

Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The effect of neuro linguistic program and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy after caesarean section.

NCT ID: NCT06070779 Recruiting - Labor Pain Clinical Trials

Neurolinguistic Programming on Labor Pain

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

THE EFFECT OF NEURO LINGUISTIC PROGRAMMING ON LABOUR PAIN, FEAR, DURATION AND MATERNAL SATISFACTION

NCT ID: NCT06068920 Recruiting - Clinical trials for Arthritis, Rheumatoid

Distress in Rheumatoid Arthritis Patients

Start date: January 30, 2023
Phase:
Study type: Observational

The goal of this observational study is to determine the frequency of psychological distress caused by the rheumatoid arthritis disease in patients with rheumatoid arthritis and to determine the factors associated with the distress. A routine rheumatoid arthritis patient examination (number of swollen and tender joints, disease activity, functional status, etc.) will be performed by the doctor to evaluate the patients. Patients will be asked to fill out the questionnaires to evaluate their functional status and distress levels. Demographic data such as age, gender, body mass index and disease duration will be recorded during routine follow-up of the patients. The duration of morning stiffness, the number of swollen and tender joints, disease activity and functional status will be evaluated by the doctor. Disease activity will be evaluated with the DAS 28 score and functional status will be evaluated with the Health Assessment Questionnaire. Rheumatoid Arthritis Distress Scale (RADS) will be used to evaluate the distress due to rheumatoid arthritis.Patients will be asked to fill out the questionnaires to evaluate their functional status and distress levels.

NCT ID: NCT06068751 Recruiting - Clinical trials for Migraine in Children

Aerobic Exercise and Neck Exercises in Pediatric Migraine Treatment

Start date: September 22, 2023
Phase: N/A
Study type: Interventional

This randomized controlled single-blind trial will include 60 pediatric migraine patients. Participants will be divided into two groups: one performing aerobic exercise, and the other conducting neck exercises. Assessments include attack frequency, severity, duration, and neck pain over three months.

NCT ID: NCT06067516 Recruiting - Sepsis Clinical Trials

Effects of Fluid Resuscitation on Capillary Refilling Time and Organ Functions in Septic Shock

Start date: October 25, 2023
Phase:
Study type: Observational

Since the ultimate target of resuscitation is the microcirculation, normal microcirculatory perfusion appears to be the primary target of ideal resuscitation in septic shock patients. In septic shock patients, microcirculation of the skin may be impaired in the early period due to early sympathetic nervous system activation. Assessment of skin perfusion has also become popular in shock resuscitation because it is easily accessible for clinical assessment. Studies in septic shock patients, showed that capillary refill time correlated with lactate levels measured at 6 hours of resuscitation and was associated with mortality. Additionally, early normalization of capillary refill time has been associated with improved survival in septic shock This study aimed to evaluate the relationship between the change in capillary filling time (microcirculation) and organ perfusion after fluid resuscitation in sepsis patients in intensive care.

NCT ID: NCT06066411 Recruiting - Preeclampsia Clinical Trials

The Effect of Massage Ball Application on Blood Pressure, Fatigue and Anxiety in Pregnant With Preeclampsia

Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of massage ball application on arterial blood pressure, fatigue and anxiety in pregnant women diagnosed with preeclampsia.

NCT ID: NCT06065709 Recruiting - Preeclampsia Clinical Trials

Mindfulness Breath Awareness Meditation and Preeclampsia

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The effect of mindfulness breath awareness meditation on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia

NCT ID: NCT06065540 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

REIMAGINE 2
Start date: September 27, 2023
Phase: Phase 3
Study type: Interventional

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two medicines called semaglutide and cagrilintide. CagriSema will be compared to the two medicines semaglutide and cagrilintide, when they are taken alone. CagriSema will also be compared to a "dummy" medicine without any active ingredient. The study will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes medicine (metformin with or without an SGLT2 inhibitor).

NCT ID: NCT06062849 Recruiting - Postoperative Pain Clinical Trials

Is it Really Necessary to Insert a Nephrostomy Tube or Double J Stent in Percutaneous Nephrolithotomy?

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

In this study, investigators aimed to compare the postoperative pain status and comfort situations depending on instruments used in the percutaneous nephrolithotomy operation

NCT ID: NCT06062420 Recruiting - Clinical trials for Neoplasms, Head and Neck

Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Start date: November 14, 2023
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to evaluate the antitumor activity and safety of novel immunotherapy combinations compared with dostarlimab in participants with Programmed death ligand 1 (PD-L1) positive Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC).